CD274 and neoplasm: However, PD-L1 expression levels can vary widely and may be influenced by the tumor microenvironment, and not all patients with PD-L1 positive tumors respond to treatment (Michielin et al., 2020[64]; Zappasodi et al., 2018[122]).